Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

Description

Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled discussion over the role the federal government plays in facilitating the creation of new pharmaceuticals for the marketplace. This report explores the issue of whether or not the substantial federal investment in health-related research and development (R&D) entitles the public to commensurate consideration in prices charged for any resulting drugs. It is intended to provide the reader with an understanding of the rationale for government support of R&D and subsequent efforts to facilitate private sector commercialization of new technologies generated from such work. Concerns surrounding ... continued below

Physical Description

26 Pages.

Creation Information

Schacht, Wendy H. June 19, 2000.

Context

This report is part of the collection entitled: Congressional Research Service Reports and was provided by UNT Libraries Government Documents Department to Digital Library, a digital repository hosted by the UNT Libraries. It has been viewed 40 times . More information about this report can be viewed below.

Who

People and organizations associated with either the creation of this report or its content.

Author

Publisher

Provided By

UNT Libraries Government Documents Department

Serving as both a federal and a state depository library, the UNT Libraries Government Documents Department maintains millions of items in a variety of formats. The department is a member of the FDLP Content Partnerships Program and an Affiliated Archive of the National Archives.

Contact Us

What

Descriptive information to help identify this report. Follow the links below to find similar items on the Digital Library.

Description

Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled
discussion over the role the federal government plays in facilitating the creation of new
pharmaceuticals for the marketplace. This report explores the issue of whether or not the
substantial federal investment in health-related research and development (R&D) entitles the
public to commensurate consideration in prices charged for any resulting drugs. It is intended
to provide the reader with an understanding of the rationale for government support of R&D
and subsequent efforts to facilitate private sector commercialization of new technologies
generated from such work. Concerns surrounding innovation in pharmaceuticals and
biotechnology are discussed within the broader context of the federal role in facilitating
technological progress.

Physical Description

26 Pages.

Language

Item Type

Identifier

Unique identifying numbers for this report in the Digital Library or other systems.

Collections

This report is part of the following collection of related materials.

Congressional Research Service Reports

The Congressional Research Service (CRS) is the public policy research arm of Congress. This legislative branch agency works exclusively for Members of Congress, their committees and their staff. This collection includes CRS reports from the mid-1970's through the present--covering a variety of topics from agriculture to foreign policy to welfare.

What responsibilities do I have when using this report?

When

Dates and time periods associated with this report.

Creation Date

  • June 19, 2000

Added to The UNT Digital Library

  • June 10, 2005, 8:03 p.m.

Description Last Updated

  • Feb. 14, 2017, 11:37 a.m.

Usage Statistics

When was this report last used?

Yesterday: 0
Past 30 days: 2
Total Uses: 40

Where

Geographical information about where this report originated or about its content.

Place Name

Publication Place

Map Information

  • map marker Automatically generated Place Name coordinates.
  • map marker Automatically generated Publication Place coordinates.
  • Repositioning map may be required for optimal printing.

Mapped Locations

Interact With This Report

Here are some suggestions for what to do next.

PDF Version Also Available for Download.

Citations, Rights, Re-Use

Schacht, Wendy H. Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship, report, June 19, 2000; Washington D.C.. (digital.library.unt.edu/ark:/67531/metacrs1092/: accessed September 23, 2017), University of North Texas Libraries, Digital Library, digital.library.unt.edu; crediting UNT Libraries Government Documents Department.